Rare diseases
Investigational molecules
Locations
Study of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer
AustriaStudy Comparing Rinatabart Sesutecan with Other Treatments for Patients with Platinum-Resistant Ovarian Cancer
AustriaStudy of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
AustriaStudy on Rezafungin Levels in Critically Ill Patients with Invasive Candidiasis Undergoing ECMO or RRT
AustriaStudy on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Relapsed or Refractory Mantle Cell Lymphoma
AustriaStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
AustriaStudy on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
AustriaStudy Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide
AustriaStudy on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer's Disease
AustriaStudy on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia
AustriaStudy of Sacituzumab Tirumotecan and Bevacizumab for Patients with Recurrent Ovarian Cancer
AustriaStudy on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
